Skip Navigation

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (16)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by De Boer, R. H.
Right arrow Articles by Smith, I. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by De Boer, R. H.
Right arrow Articles by Smith, I. E.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Annals of Oncology 11:1147-1153, 2000
© 2000 European Society for Medical Oncology

research-article

Multimodality therapy in inflammatory breast cancer: Is there a place for surgery?

R. H. De Boer1, W. H. Allum2, S. R. Ebbs3, G. P. H. Gui1, S. R. D. Johnston1, N. P. M. Sacks1, G. Walsh1, S. Ashley1 and I. E. Smith1,

1Breast Unit, Royal Marsden Hospital Trust and Institute of Cancer Research London
2Epsom General Hospital Epsom
3Mayday University Hospital Croydon, Surrey, UK

Correspondence to: I. E. Smith, MD, FRCP, FRCPE Head of Section of Medicine The Royal Marsden NHS Trust Fulham Rd London, SW3 8JJ UK E-mail. ians{at}icr.ac.uk

BACKGROUND:: In many centres surgery is used as part of a combined modality approach to the treatment of inflammatory breast cancer (IBC). Nevertheless, its value is controversial given the high risk of metastatic relapse and poor overall prognosis. We have reviewed patients with true IBC prospectively treated at the Royal Marsden Hospital in chemotherapy trials to assess further the role of surgery as part of combined modality treatment.

PATIENTS AND METHODS:: Fifty-four patients who had responsive or stable disease to primary chemotherapy went on to have either radiotherapy alone (n = 35) or surgery plus radiotherapy (n = 19); the decision on surgery was based partly on clinician preference and partly on clinical response.

RESULTS:: The 35 patients undergoing radiotherapy alone had a median progression-free survival (PFS) of 16 months and median overall survival (OS) of 35 months. Twenty-four patients (69%) have relapsed with a total of twelve (34%) relapsing locally. In comparison, the 19 patients receiving both surgery and radiotherapy had a PFS of 20 months, and a median OS of 35 months. Fifteen patients (79%) have relapsed, eight (42%) of these locally. None of these differences were statistically significant.

CONCLUSIONS:: These results do not suggest a clinical advantage for surgery in addition to chemotherapy and radiotherapy for patients with IBC. They support the need for a prospective randomised trial to address this question.

breast, cancer, inflammatory, multimodality, surgery, therapy


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Vet Rec.Home page
M. Clemente, P. J. De Andres, L. Pena, and M. D. Perez-Alenza
Survival time of dogs with inflammatory mammary cancer treated with palliative therapy alone or palliative therapy plus chemotherapy
Vet Rec., July 18, 2009; 165(3): 78 - 81.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
M. Panades, I. A. Olivotto, C. H. Speers, T. Shenkier, T. A. Olivotto, L. Weir, S. J. Allan, and P. T. Truong
Evolving Treatment Strategies for Inflammatory Breast Cancer: A Population-Based Survival Analysis
J. Clin. Oncol., March 20, 2005; 23(9): 1941 - 1950.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
J. A. Low, A. W. Berman, S. M. Steinberg, D. N. Danforth, M. E. Lippman, and S. M. Swain
Long-Term Follow-Up for Locally Advanced and Inflammatory Breast Cancer Patients Treated With Multimodality Therapy
J. Clin. Oncol., October 15, 2004; 22(20): 4067 - 4074.
[Abstract] [Full Text] [PDF]

Home page
 The OncologistHome page
S. H. Giordano
Update on Locally Advanced Breast Cancer
Oncologist, December 1, 2003; 8(6): 521 - 530.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.